IDEXX Laboratories Inc
IDXX.O- Latest Trade
- trading lower459.53USD
- -5.75
- 1.24%
- As of Jun 7 2023. Values delayed up to 15 minutes
- Today's Range
- 456.34 - 464.77
- 52 Week Range
- 317.06 - 515.79
- Previous Close
- 465.28
- Open
- 464.49
- Volume
- 371,655.00
- 3 Month Average Trading Volume
- 8.26
- Shares Out (Mil)
- 83.00
- Market Cap
- 38,620.54
- Forward P/E
- 48.00
- Dividend Yield
- 0.00
Key Statistics
2.25 mean rating - 12 analysts
- P/E Excl. Extra Items (TTM)
- 55.99
- Price To Sales (TTM)
- 11.26
- Price To Book (Quarterly)
- 45.92
- Price To Cash Flow (Per Share TTM)
- 47.51
- Total Debt/Total Equity (Quarterly)
- 143.01
- Long Term Debt/Equity (Quarterly)
- 82.79
- Return On Investment (TTM)
- 41.57
- Return On Equity (TTM)
- 25.89
2021 (millions USD)
About IDEXX Laboratories Inc (IDXX.O)
Company Information
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also offers human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment provides products and services for veterinarians and the biomedical research community, primarily related to diagnostics and information management. The Water segment provides testing solutions for the detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry. The Company has sales offices outside the United States in all regions, including Africa, Asia Pacific, Canada, Europe, the Middle East, and Latin America.
Address
One Idexx DriveWESTBROOK, ME
04092-2041
United States
Industry
Fish/Livestock
Executive Leadership
- Lawrence D. Kingsley
- Independent Chairman of the Board
- Jonathan Mazelsky
- President, Chief Executive Officer, Director
- Brian P. Mckeon
- Chief Financial Officer, Executive Vice President, Treasurer
- Michael P. Johnson
- Chief Human Resource Officer, Senior Vice President
- Martin Smith
- Executive Vice President, Chief Technology Officer
- Sharon E. Underberg
- Executive Vice President, General Counsel, Corporate Secretary
- Michael J. Lane
- Executive Vice President and General Manager, Global Reference Laboratories and Information Technology
- Tina Hunt
- Executive Vice President - Strategy, Sector Development and Global Operations
- James F. Polewaczyk
- Executive Vice President, Chief Commercial Officer
- Jonathan W. Ayers
- Director
- Bruce L. Claflin
- Independent Director
- Asha S. Collins
- Independent Director
- Stuart M. Essig
- Independent Director
- Daniel M. Junius
- Independent Director
- Sam A. Samad
- Independent Director
- M. Anne Szostak
- Independent Director
- Sophie V. Vandebroek
- Independent Director
Latest News
- BusinessZoetis reports weak pet products sales, shares fall
Zoetis Inc on Thursday reported weaker-than-expected sales in its largest business unit as distributors de-stocked on pet products.
Financials
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,942.40 | 1.18% |
| Copper | 721.00 | 0.20% |
| Brent Crude Oil | 77.21 | 1.21% |
| CBOT Soybeans | 1,368.75 | 1.15% |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,274.96 | 0.21% |
| Euro STOXX 50 | 4,291.91 | 0.08% |
| FTSE 100 | 7,624.34 | 0.05% |
| Nikkei 225 | 31,913.74 | 1.82% |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes